Alkeon Capital Management
ARNA

Alkeon Capital Management’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Alkeon Capital Management’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-1,741,531
Closed -$104M – 184
2021
Q3 		$104M Sell
1,741,531
-15,405
-0.9% -$910K 0.18% 100
2021
Q2 		$120M Sell
1,756,936
-8,233
-0.5% -$537K 0.18% 97
2021
Q1 		$122M Buy
1,765,169
+13,602
+0.8% +$1.05M 0.18% 92
2020
Q4 		$135M Buy
1,751,567
+11,567
+0.7% +$867K 0.22% 77
2020
Q3 		$130M Hold
1,740,000
– – 0.24% 70
2020
Q2 		$110M Buy
1,740,000
+990,000
+132% +$54.5M 0.28% 67
2020
Q1 		$31.5M Buy
+750,000
New +$34.4M 0.13% 95

Other funds holding ARNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Alkeon Capital Management's ARNA Position: Q4 2021 in Review

Alkeon Capital Management sold out of Arena Pharmaceuticals Inc (ARNA) in Q4 2021, closing a stake of 1,741,531 shares — an estimated $104M sold.

Alkeon Capital Management first reported a position in ARNA in Q1 2020 and held it in 7 quarters. The position peaked at $135M in Q4 2020. 317 funds tracked by Wall St. Rank hold ARNA as of Q4 2021.

  • Alkeon Capital Management reported no remaining Arena Pharmaceuticals Inc position as of Q4 2021 after selling out during the quarter.
  • Alkeon Capital Management sold 1,741,531 Arena Pharmaceuticals Inc shares in Q4 2021, an estimated $104M.
  • Alkeon Capital Management first reported a position in Arena Pharmaceuticals Inc in Q1 2020 and held it in 7 quarters.
  • Alkeon Capital Management's Arena Pharmaceuticals Inc position peaked at $135M in Q4 2020.
  • 317 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q4 2021.

Based on Alkeon Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.